An accomplished pharmacist, Sherif El-Refai is now engaged in a PhD program in pharmaceutical sciences, with a focus on clinical and experimental therapeutics, at the University of Kentucky (UK). Sherif El-Refai also conducts research on lung cancer and works as an oncology pharmacist at the UK Markey Cancer Center.
UK Markey recently announced that the UK Resource Center for Stable Isotope-Resolved Metabolomics (RC-SIRM) hosted the 2015 RC-SIRM Symposium and Workshop at the Bio Pharmacy Complex on the UK campus. At the 12-day interactive workshop, participants explored how to apply SIRM, which facilitates functional examination of gene dysregulation in lung cancer, as well as “bench to bedside” translational investigations and biochemistry studies in the life sciences.
The workshop was preceded by a one-day symposium featuring presentations by experts in the field of SIRM. According to the Resource Center for SIRM, a facility funded by the National Institutes of Health, researchers utilize stable isotope labeling to study metabolic alterations and improve the diagnosis and treatment of various conditions, including cancer, cardiac disorders, and brain conditions. The keynote speaker was Chi Van Dang, MD, PhD, from the Abramson Cancer Center at the University of Pennsylvania, whose presentation was followed by lectures by other experts from around the world.